Harbor Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,761
| Closed | -$1.5M | – | 83 |
|
|
2025
Q1 | $1.5M | Sell |
11,761
-55
| -0.5% | -$7.46K | 0.5% | 49 |
|
|
2024
Q4 | $1.56M | Sell |
11,816
-588
| -5% | -$82.7K | 0.51% | 48 |
|
|
2024
Q3 | $1.81M | Sell |
12,404
-385
| -3% | -$55.7K | 0.59% | 45 |
|
|
2024
Q2 | $1.76M | Buy |
12,789
+15
| +0.1% | +$2K | 0.61% | 43 |
|
|
2024
Q1 | $1.75M | Hold |
12,774
| – | – | 0.6% | 48 |
|
|
2023
Q4 | $1.74M | Hold |
12,774
| – | – | 0.62% | 48 |
|
|
2023
Q3 | $1.56M | Buy |
12,774
+130
| +1% | +$16.5K | 0.57% | 52 |
|
|
2023
Q2 | $1.61M | Sell |
12,644
-50
| -0.4% | -$6.5K | 0.57% | 50 |
|
|
2023
Q1 | $1.64M | Hold |
12,694
| – | – | 0.63% | 50 |
|
|
2022
Q4 | $1.67M | Buy |
12,694
+1,213
| +11% | +$157K | 0.68% | 45 |
|
|
2022
Q3 | $1.34M | Sell |
11,481
-635
| -5% | -$78.9K | 0.62% | 45 |
|
|
2022
Q2 | $1.42M | Sell |
12,116
-10,895
| -47% | -$1.29M | 0.62% | 45 |
|
|
2022
Q1 | $3M | Sell |
23,011
-175
| -0.8% | -$22.8K | 1.2% | 31 |
|
|
2021
Q4 | $3.54M | Sell |
23,186
-845
| -4% | -$131K | 1.44% | 27 |
|
|
2021
Q3 | $3.88M | Sell |
24,031
-4,950
| -17% | -$833K | 1.69% | 21 |
|
|
2021
Q2 | $4.74M | Sell |
28,981
-3,585
| -11% | -$552K | 2.14% | 16 |
|
|
2021
Q1 | $4.9M | Sell |
32,566
-115
| -0.4% | -$18.3K | 1.95% | 14 |
|
|
2020
Q4 | $4.95M | Sell |
32,681
-530
| -2% | -$75.7K | 2.62% | 10 |
|
|
2020
Q3 | $4.5M | Sell |
33,211
-200
| -0.6% | -$27.1K | 4.41% | 9 |
|
|
2020
Q2 | $4.57M | Sell |
33,411
-740
| -2% | -$94.3K | 4.63% | 8 |
|
|
2020
Q1 | $3.68M | Sell |
34,151
-380
| -1% | -$43.8K | 3.95% | 9 |
|
|
2019
Q4 | $4.16M | Sell |
34,531
-625
| -2% | -$69.7K | 3.46% | 13 |
|
|
2019
Q3 | $3.5M | Buy |
35,156
+180
| +0.5% | +$18.8K | 3.05% | 16 |
|
|
2019
Q2 | $3.82M | Sell |
34,976
-320
| -0.9% | -$34K | 3.37% | 12 |
|
|
2019
Q1 | $3.95M | Buy |
35,296
+1,295
| +4% | +$142K | 3.53% | 11 |
|
|
2018
Q4 | $3.28M | Buy |
34,001
+10
| +0% | +$1.06K | 3.24% | 10 |
|
|
2018
Q3 | $4.14M | Sell |
33,991
-50
| -0.1% | -$5.89K | 3.59% | 8 |
|
|
2018
Q2 | $3.74M | Buy |
34,041
+330
| +1% | +$35.3K | 3.36% | 11 |
|
|
2018
Q1 | $3.6M | Buy |
33,711
+28,665
| +568% | +$3.18M | 3.3% | 10 |
|
|
2017
Q4 | $539K | Buy |
+5,046
| New | +$539K | 0.52% | 34 |
|
Other funds holding IBB
Harbor Advisory's IBB Position: Q2 2025 in Review
Harbor Advisory sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 11,761 shares — an estimated $1.5M sold.
Harbor Advisory first reported a position in IBB in Q4 2017 and held it in 30 quarters. The position peaked at $4.95M in Q4 2020. 800 funds tracked by Wall St. Rank hold IBB as of Q2 2025.
- Harbor Advisory reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
- Harbor Advisory sold 11,761 iShares Biotechnology ETF shares in Q2 2025, an estimated $1.5M.
- Harbor Advisory first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 30 quarters.
- Harbor Advisory's iShares Biotechnology ETF position peaked at $4.95M in Q4 2020.
- 800 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.
Based on Harbor Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.